// App-Quantinova.ai

13143 : KvLQT1 Autoantibodies Accelerate Repolarization and Increase Susceptibility to Ventricular Tachyarrhythmias in an Experimental Model

Researchers

Presenter

  • Ange Maguy

Principal Investigators

  • Patrick Vigneault

  • Dierk Thomas

  • Stanley Nattel

Medical Centers

  • Univ de Montreal and Montreal Heart Inst, Montreal, QC, Canada

  • University Clinic Heidelberg, Heidelberg, Germany

Locations

  • Canada

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Dilated cardiomyopathy

  • Short QT syndrome

  • Heart muscle disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim